ADAR1 Capital Management »

Gores Holding Ix Inc-cl A shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Gores Holding Ix Inc-cl A (GHIX) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Gores Holding Ix Inc-cl A

Tip: Access up to 7 years of quarterly data

All positions including Gores Holding Ix Inc-cl A held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gores Holding Ix Inc-cl A by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $316k 30k 10.50

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Roivant Sciences SHS (ROIV)
Cytokinetics Com New (CYTK)
Arbutus Biopharma (ABUS)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Cerevel Therapeutics Hldng I (CERE)
Mirati Therapeutics
Merck & Co (MRK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Immunovant (IMVT)
Viking Therapeutics (VKTX)
Protagonist Therapeutics (PTGX)

View all positions for ADAR1 Capital Management

Top funds holding Gores Holding Ix Inc-cl A

CNH Partners
Westchester Capital Management
Nomura Holdings
Saba Capital Management
Moore Capital Management
Goldman Sachs Group
TD Asset Management
Schechter Investment Advisors
Barclays
Millennium Management
Vivaldi Asset Management
Kim
Alberta Investment Management Corporation
Rivernorth Capital Management
Davidson Kempner Capital Management

View all funds holding Gores Holding Ix Inc-cl A